Literature DB >> 24379601

Acute cholestatic hepatitis caused by amoxicillin/clavulanate.

Daniel Oliveira Beraldo1, Joanderson Fernandes Melo1, Alexandre Vidal Bonfim1, Andrei Alkmim Teixeira1, Ricardo Alkmim Teixeira1, André Loyola Duarte1.   

Abstract

Amoxicillin/clavulanate is a synthetic penicillin that is currently commonly used, especially for the treatment of respiratory and cutaneous infections. In general, it is a well-tolerated oral antibiotic. However, amoxicillin/clavulanate can cause adverse effects, mainly cutaneous, gastrointestinal, hepatic and hematologic, in some cases. Presented here is a case report of a 63-year-old male patient who developed cholestatic hepatitis after recent use of amoxicillin/clavulanate. After 6 wk of prolonged use of the drug, he began to show signs of cholestatic icterus and developed severe hyperbilirubinemia (total bilirubin > 300 mg/L). Diagnostic investigation was conducted by ultrasonography of the upper abdomen, serum tests for infection history, laboratory screening of autoimmune diseases, nuclear magnetic resonance (NMR) of the abdomen with bile duct-NMR and transcutaneous liver biopsy guided by ultrasound. The duration of disease was approximately 4 mo, with complete resolution of symptoms and laboratory changes at the end of that time period. Specific treatment was not instituted, only a combination of anti-emetic (metoclopramide) and cholestyramine for pruritus.

Entities:  

Keywords:  Amoxicillin/Clavulanate; Drug reactions; Hepatitis; Hepatology; Hyperbilirubinemia

Mesh:

Substances:

Year:  2013        PMID: 24379601      PMCID: PMC3870529          DOI: 10.3748/wjg.v19.i46.8789

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  14 in total

Review 1.  Criteria of drug-induced liver disorders. Report of an international consensus meeting.

Authors:  C Bénichou
Journal:  J Hepatol       Date:  1990-09       Impact factor: 25.083

2.  Granulomatous hepatitis due to combination of amoxicillin and clavulanic acid.

Authors:  C Silvain; E Fort; P Levillain; J Labat-Labourdette; M Beauchant
Journal:  Dig Dis Sci       Date:  1992-01       Impact factor: 3.199

3.  Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis.

Authors:  V A Maria; R M Victorino
Journal:  Hepatology       Date:  1997-09       Impact factor: 17.425

4.  HLA association of amoxicillin-clavulanate--induced hepatitis.

Authors:  M L Hautekeete; Y Horsmans; C Van Waeyenberge; C Demanet; J Henrion; L Verbist; R Brenard; C Sempoux; P P Michielsen; P S Yap; J Rahier; A P Geubel
Journal:  Gastroenterology       Date:  1999-11       Impact factor: 22.682

5.  History of drug-induced hepatitis and risk of amoxicillin/clavulanate-induced hepatotoxicity.

Authors:  R Schey; Y Avni; R Bruck; H Shirin
Journal:  Ann Pharmacother       Date:  2001-09       Impact factor: 3.154

Review 6.  Hepatotoxicity of antimicrobial agents.

Authors:  Steven John Brown; Paul Vincent Desmond
Journal:  Semin Liver Dis       Date:  2002       Impact factor: 6.115

7.  Hepatitis associated with amoxicillin/clavulanic acid and/or ciprofloxacin.

Authors:  Syed A Zaidi
Journal:  Am J Med Sci       Date:  2003-01       Impact factor: 2.378

8.  Focal destructive cholangiopathy associated with amoxycillin/clavulanic acid (Augmentin).

Authors:  N G Ryley; K A Fleming; R W Chapman
Journal:  J Hepatol       Date:  1995-09       Impact factor: 25.083

Review 9.  Acute liver failure due to amoxicillin and amoxicillin/clavulanate.

Authors:  Robert J Fontana; A Obaid Shakil; Joel K Greenson; Ian Boyd; William M Lee
Journal:  Dig Dis Sci       Date:  2005-10       Impact factor: 3.487

10.  A case of amoxicillin-induced hepatocellular liver injury with bile-duct damage.

Authors:  Ju Seung Kim; Young Rock Jang; Ji Won Lee; Jin Yong Kim; Young Kul Jung; Dong Hae Chung; Oh Sang Kwon; Yun Soo Kim; Duck Joo Choi; Ju Hyun Kim
Journal:  Korean J Hepatol       Date:  2011-09
View more
  3 in total

1.  Synergistic Cytotoxicity from Drugs and Cytokines In Vitro as an Approach to Classify Drugs According to Their Potential to Cause Idiosyncratic Hepatotoxicity: A Proof-of-Concept Study.

Authors:  Ashley R Maiuri; Bronlyn Wassink; Jonathan D Turkus; Anna B Breier; Theresa Lansdell; Gurpreet Kaur; Sarah L Hession; Patricia E Ganey; Robert A Roth
Journal:  J Pharmacol Exp Ther       Date:  2017-07-07       Impact factor: 4.030

2.  Severe Case of Cholestatic Hepatitis From Amoxicillin/Clavulanic Acid.

Authors:  Lokesh Goyal; Anirudh K Madabhushi; Mariam S Siddiqi; Santosh Kale; Deobrat C Mallick
Journal:  Cureus       Date:  2022-06-09

3.  Delayed Presentation of Drug-Induced Hepatic Injury.

Authors:  Shohana Ahmed; Nirmal K Onteddu; Ali Jabur; Sai Swarupa R Vulasala; Swapna Kolli
Journal:  Cureus       Date:  2020-08-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.